Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
318 studies found for:    "Diabetic Retinopathy"
Show Display Options
Rank Status Study
21 Completed Avastin for PDR (Proliferative Diabetic Retinopathy)
Conditions: Retinal Detachment;   Diabetic Retinopathy
Interventions: Drug: Avastin (bevacizumab);   Other: Sham injection
22 Completed Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
23 Completed Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)
Condition: Diabetic Retinopathy
Intervention:
24 Completed A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Qi ming granula;   Drug: Placebo Comparator
25 Not yet recruiting Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases
Condition: Diabetic Retinopathy
Interventions: Other: Tele-medicine;   Other: Conventional referral
26 Unknown  Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: intravitreal injection of bevacizumab;   Procedure: panretinal photocoagulation
27 Completed Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Triamcinolone Acetonide 4 mg intravitreal injection;   Procedure: Panretinal photocoagulation
28 Completed Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Retinal Neovascularization
Interventions: Drug: Ranibizumab;   Procedure: Panretinal Photocoagulation
29 Completed Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: doxycycline monohydrate;   Drug: Placebo
30 Completed Macular Hole in Diabetic Retinopathy
Conditions: Macular Hole;   Proliferative Diabetic Retinopathy
Intervention:
31 Enrolling by invitation Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
Conditions: Macular Edema;   Cataract;   Diabetic Retinopathy
Interventions: Drug: Perioperative Diclofenac eye-drops administration;   Drug: placebo
32 Completed Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Retinal Diseases;   Eye Diseases;   Diabetic Angiopathies;   Vascular Diseases;   Cardiovascular Diseases
Interventions: Drug: Ranibizumab;   Procedure: Laser therapy
33 Completed Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Diabetic Eye Problems;   Retinal Disorders
Interventions: Drug: Qideng Mingmu capsule;   Drug: Placebo Comparator
34 Completed Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Octreotide Acetate in Microspheres 20 mg;   Drug: Octreotide Acetate in Microspheres;   Drug: Placebo
35 Completed Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Octreotide Acetate in Microspheres;   Drug: Placebo
36 Active, not recruiting Biomarkers of Diabetic Retinopathy Progression
Conditions: Type 2 Diabetes Mellitus;   Mild Nonproliferative Diabetic Retinopathy
Intervention:
37 Completed Evaluation of Doxycyline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: doxycycline monohydrate;   Drug: placebo
38 Terminated Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Trientine Hydrochloride;   Drug: Oral placebo capsules
39 Completed HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population
Conditions: Diabetes Mellitus Type 2;   Proliferative Diabetic Retinopathy
Intervention: Procedure: blood sample
40 Terminated Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Octreotide acetate in microspheres

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years